Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Acupressure for stress: new study targets women with qi stagnation

NCT ID NCT07508748

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether non-invasive acupoint stimulation (like acupressure) can lower stress in women aged 20-40 who have a 'qi stagnation' constitution and high stress levels. 90 women will take part, with some receiving real treatment, some a placebo, and some acting as a healthy comparison group. The main goal is to see if stress scores improve after the treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 90 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Apr 2026

An estimate. Start dates often move.

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

20 to 40 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female, aged 20-40 years. * Regular daily routine with relatively fixed wake-up and bedtimes, sufficient sleep (7-9 hours), regular diet, moderate physical activity, and avoidance of shift work. * Intact structure of major organ systems, with no active diseases or pathological damage. * Regular menstrual cycle (21-35 days) and normal menstrual period (3-7 days). * For the experimental group (Qi Yu constitution group): * Perceived Stress Scale (PSS-14) score ≥ 43. * Qi Yu Constitution Subscale score ≥ 40. * Diagnosis by a qualified TCM physician according to standard procedures, confirming characteristics of Qi Yu constitution, including (physical symptoms partially required): * Body type: Tending to be thin. * Psychological characteristics: Introverted, unstable, sensitive, suspicious, with significant emotional fluctuations. * Somatic symptoms: Fullness or migrating pain in the chest and hypochondrium, frequent sighing; sensation of a foreign body in the throat (globus hystericus); sleep disturbances (difficulty falling asleep, early awakening). Poor appetite, frequent belching. * Tongue and pulse: Pale red tongue with thin white coating, wiry and thin pulse. * For the control group (non-Qi Yu constitution group): * Perceived Stress Scale (PSS-14) score ≤ 42. * Qi Yu Constitution Subscale score \< 30. * No relevant clinical manifestations upon TCM examination. * Signed informed consent form, voluntarily participating in the trial. * Willing to comply with all testing requirements. * No infection or bleeding tendency on the skin of the five acupoint areas (GV20/Baihui, LI4/Hegu, LR3/Taichong, PC6/Neiguan, SP6/Sanyinjiao), not affecting the use of the study products. Exclusion Criteria: * Participation in any other clinical trial evaluation within the past 1 month. * Presence of organic diseases, such as various malignant tumors, certain chronic diseases (heart disease, diabetes, anemia, etc.), certain gynecological diseases (uterine fibroids, endometriosis, severe mammary hyperplasia, etc.), or certain endocrine diseases (hyperthyroidism or hypothyroidism, etc.). * Individuals with hypothalamic-pituitary-adrenal (HPA) axis dysfunction, such as those with endocrine diseases (e.g., hyper/hypothyroidism, Cushing's syndrome, congenital adrenal hyperplasia, primary chronic adrenocortical insufficiency). * Individuals diagnosed with major depressive disorder or anxiety disorder, bipolar disorder, schizophrenia, etc. * Use of antidepressants, anti-anxiety medications, glucocorticoids, or immunosuppressants within the past 4 weeks. * Recent (within the past 3 months) suicidal ideation or self-harm behavior. * Receipt of acupuncture, massage, or other TCM treatments or psychological interventions (e.g., cognitive behavioral therapy) within the past 4 weeks. * Suffering from autoimmune diseases requiring long-term use of hormones. * Alcohol or drug dependence. * Experienced major stressful life events (e.g., bereavement of a close relative suffering a major psychological blow) in the past year. * Physically weak or unable to tolerate the arithmetic stress in the MIST task. * Conditions such as epilepsy, hypertension, or heart disease that are unsuitable for undergoing induced psychological stress. * Inability to cooperate in completing the MIST task (e.g., due to visual/auditory impairment, cognitive dysfunction). * Inability or unwillingness to attend all study visits and comply with the treatment regimen.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acupoints are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Shanghai China-norm Quality Technical Service Co., Ltd., Shanghai, Shanghai 200072

    Shanghai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.